Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 789 | 0 | 0 | 0 | 144,927 |
| Gross Profit | 789 | N/A | N/A | N/A | 144,927 |
| Operating Expenses | 94,760 | 121,315 | 195,097 | 179,914 | 209,420 |
| Operating Income | -93,971 | -121,315 | -195,097 | -179,914 | -64,493 |
| Interest Expense | 0 | 0 | 2,468 | 6,020 | 2,910 |
| Other Income | 99,667 | -4,456 | 7,435 | 2,353 | 1,825 |
| Pre-tax Income | 5,696 | -125,771 | -190,130 | -183,581 | -65,578 |
| Net Income Continuous | 5,696 | -125,771 | -190,130 | -183,581 | -65,578 |
| Net Income Discontinuous | N/A | 125,907 | 76,406 | -66,576 | N/A |
| Net Income | $5,696 | $136 | $-113,724 | $-250,157 | $-65,578 |
| EPS Basic Total Ops | 0.64 | 0.02 | -17.77 | -46.20 | -14.40 |
| EPS Basic Continuous Ops | 0.64 | -16.20 | -29.71 | -34.00 | -14.30 |
| EPS Basic Discontinuous Ops | N/A | 16.20 | 11.94 | -12.40 | N/A |
| EPS Diluted Total Ops | 0.64 | 0.02 | -17.77 | -46.20 | -14.40 |
| EPS Diluted Continuous Ops | 0.64 | -16.20 | -29.71 | -34.00 | -14.30 |
| EPS Diluted Discontinuous Ops | N/A | 16.20 | 11.94 | -12.40 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.64 | -16.20 | -17.80 | -46.20 | -14.40 |
| EBITDA(a) | $-89,838 | $-114,434 | $-187,951 | $-171,892 | $-55,522 |